Casecontrol association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder

International Journal of Psychiatry in Clinical Practice

Volumn 16, Issue 1, 2012, Pages 18-26

  Chiesa, Alberto ^a   Crisafulli, Concetta ^b   Porcelli, Stefano ^a   Balzarro, Beatrice ^a   Han, Changsu ^c   Patkar, Ashwin A ^d   Lee, Soo Jung ^e   Park, Moon Ho ^c   Pae, Chi Un ^d,e   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Korea University College of Medicine   (South Korea)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e The Catholic University of Korea   (South Korea)

Author keywords

Bipolar disorder; GRIA1; GRIA2; GRIA4

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BUSPIRONE; CLONAZEPAM; GENOMIC DNA; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 4; LITHIUM; LORAZEPAM; MOOD STABILIZER; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT; VALPROIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 4; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MOOD DISORDER; NEUROTRANSMISSION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE; ANALYSIS OF VARIANCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETICS; GENOTYPE; HOSPITALIZATION; KOREA; METABOLISM; PSYCHOLOGICAL RATING SCALE;

ADULT; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, AMPA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84856921651     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2011.617459     Document Type: Article

References (36)

1. Danysz W, Parsons CG. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 1998;50(4):597-664. (Pubitemid 29028813)
2. Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 2008;28(6):631-7.
3. Nakanishi N, Shneider NA, Axel R. A family of glutamate receptor genes: evidence for the formation of heteromul-timeric receptors with distinct channel properties. Neuron 1990;5(5):569-81.
4. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocam-pal CA1/CA2 neurons. J Neurosci 1996;16(6):1982-9. (Pubitemid 26144011)
5. Wenthold RJ, Yokotani N, Doi K, Wada K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain. J Biol Chem 1992;267(1):501-7.
6. Hollmann M, Hartley M, Heinemann S. Ca2+permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991;252(5007):851-3. (Pubitemid 121000528)
7. Bleakman D, Alt A, Witkin JM. AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets 2007;6(2):117-26. (Pubitemid 46681772)
8. Schmitt WB, Sprengel R, Mack V, Draft RW, Seeburg PH, Deacon RM, et al. Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nat Neurosci 2005;8(3):270-2. (Pubitemid 40300181)
9. Kerner B, Jasinska AJ, DeYoung J, Almonte M, Choi OW, Freimer NB. Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder. Am J Med Genet B Neuropsychi-atr Genet 2009;150B(1):24-32.
10. Magri C, Gardella R, Barlati SD, Podavini D, Iatropoulos P, Bonomi S, et al. Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample. Am J Med Genet B Neuropsychiatr Genet 2006;141B(3):287-93.
11. O'Connor JA, Hemby SE. Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia. Schizophr Res 2007;97(1-3):277-88. (Pubitemid 350088405)
12. Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007;32(9): 1888-902. (Pubitemid 47258508)
13. Black MD. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology (Berlin) 2005;179(1):154-63. (Pubitemid 40584805)
14. Ekholm JM, Kieseppa T, Hiekkalinna T, Partonen T, Paunio T, Perola M, et al. Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder. Hum Mol Genet 2003;12(15):1907-15. (Pubitemid 36944144)
15. McInnis MG, Lan TH, Willour VL, McMahon FJ, Simpson SG, Addington AM, et al. Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol Psychiatry 2003;8(3):288-98. (Pubitemid 36712922)
16. Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R, et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999; 65(4):1114-24. (Pubitemid 30462969)
17. Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J, et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009;166(6):718-25.
18. Seelan RS, Khalyfa A, Lakshmanan J, Casanova MF, Parthasarathy RN. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 2008;151(4):1184-97.
19. Du J, Creson TK, Wu LJ, Ren M, Gray NA, Falke C, et al. The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci 2008;28(1):68-79.
20. Makino C, Fujii Y, Kikuta R, Hirata N, Tani A, Shibata A, et al. Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region. Am J Med Genet B Neuropsychiatr Genet 2003;116B(1):17-22. (Pubitemid 37063607)
21. Guo S, Shi Y, Zhao X, Duan S, Zhou J, Meng J, et al. No genetic association between polymorphisms in the AMPA receptor subunit GluR4 gene (GRIA4) and schizophrenia in the Chinese population. Neurosci Lett 2004;369(2):168-72. (Pubitemid 39265421)
22. Magri C, Gardella R, Valsecchi P, Barlati SD, Guizzetti L, Imperadori L, et al. Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients. Am J Med Genet B Neu-ropsychiatr Genet 2008;147B(6):745-53.
23. Giegling I, Drago A, Dolzan V, Plesnicar BK, Schafer M, Hartmann AM, et al. Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. Pharmacogenet Genomics 2011;21(4):206-16.
24. Cherlyn SY, Woon PS, Liu JJ, Ong WY, Tsai GC, Sim K. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci Biobehav Rev 2010;34(6):958-77.
25. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry Res 1998;59(Suppl 20):22-33;quiz 34-57.
26. Serretti A, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, et al. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Psychiatry Res 2011;189(1):26-32.
27. Pae CU, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, et al. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology 2011; In press
28. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35. (Pubitemid 9006756)
29. Hirschfeld RM, Keck PE Jr, Kramer M, Karcher K, Canuso C, Eerdekens M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004;161(6):1057-65. (Pubitemid 38735992)
30. Perlis RH, Baker RW, Zarate CA Jr, Brown EB, Schuh LM, Jamal HH, et al. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 2006; 67(11):1747-53. (Pubitemid 44955156)
31. StatSoft I. STATISTICA for Windows. StatSoft Italia srl, Tulsa, OK; 1995.
32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21(2):263-5. (Pubitemid 40202029)
33. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
34. Grigoroiu-Serbanescu M, Martinez M, Nothen MM, Grinberg M, Sima D, Propping P, et al. Different familial transmission patterns in bipolar I disorder with onset before and after age 25. Am J Med Genet 2001;105(8):765-73. (Pubitemid 33101480)
35. Sullivan PF. Spurious genetic associations. Biol Psychiatry 2007;61(10):1121-6. (Pubitemid 46669468)
36. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159(3):469-73. (Pubitemid 34184745)